In a lung cancer mouse model, exposure to additional oxygen (in breathing O2, levels rose from 21% to 60%) demonstrated that exogenous oxygen supplementation can reduce HIF-1α levels along with its downstream proteins, reversing the hypoxic, adenosine-rich TME, thereby promoting tumor regression (67). This evidence concerns the gene HIF1A and neoplasm.